Quick Answer
Medical device regulation in India is governed by the Medical Devices Rules 2017 under the Drugs and Cosmetics Act 1940, administered by the Central Drugs Standard Control Organisation (CDSCO). Manufacturers must obtain CDSCO registration based on device risk classification (Class A to D), with additional BIS certification and clinical investigation requirements for higher-risk devices.
India’s medical device sector has grown into one of the most significant healthcare markets in Asia, currently valued at approximately USD 11 billion and expanding at an annual rate of approximately 15%. This growth has accelerated regulatory attention. The Medical Devices Rules 2017, enforced by the Central Drugs Standard Control Organisation (CDSCO), now governs the registration, manufacturing, import, sale, and distribution of medical devices across the country.
For domestic manufacturers, multinational corporations, and healthcare investors entering India’s medical device space, understanding the CDSCO compliance pathway is not optional. Non-compliance can result in product bans, import rejections, and significant legal exposure.
This guide provides a structured overview of the legal framework, device classification, CDSCO registration steps, Bureau of Indian Standards (BIS) certification requirements, clinical investigation obligations, intellectual property (IP) considerations, and foreign direct investment (FDI) rules applicable to medical devices in India as of 2026.
Altacit Global advises clients at every stage of this process, from pre-registration strategy to post-approval compliance.
What Is the Legal Framework Governing Medical Devices in India?
Medical device regulation in India operates under the Drugs and Cosmetics Act 1940, as amended, with the Medical Devices Rules 2017 serving as the primary subordinate legislation. The Medical Devices Rules 2017 came into force on April 1, 2020 for non-notified device categories, and were extended to cover all medical devices from April 1, 2021 onward.
Currently, 23 device categories are subject to compulsory CDSCO registration as notified devices. All remaining devices also require registration under the expanded scope effective April 1, 2021.
A significant legislative development is the proposed Drugs, Medical Devices and Cosmetics Bill 2023, which is expected to replace the Drugs and Cosmetics Act 1940. This Bill introduces a dedicated statutory framework for medical devices, separating them from pharmaceutical regulation. Manufacturers and investors should monitor its legislative progress closely, as it may alter licensing requirements, penalty structures, and compliance timelines.
CDSCO, operating under the Ministry of Health and Family Welfare, functions as India’s national regulatory authority for medical devices. All registrations, licenses, and approvals are processed through the SUGAM portal (sugam.pharma.gov.in).
How Are Medical Devices Classified in India Under MDR 2017?
The Medical Devices Rules 2017 classify medical devices into four risk-based classes. The classification determines the complexity of the registration process, the documentation required, and whether clinical investigation data is mandatory.
Class | Risk Level | Examples |
Class A | Low risk | Tongue depressors, examination gloves, bandages |
Class B | Low-moderate risk | Hypodermic needles, suction equipment, basic diagnostic devices |
Class C | Moderate-high risk | Lung ventilators, bone fixation plates, dialysis equipment |
Class D | High risk | Active implantable devices, heart valves, HIV diagnostic kits |
Class A devices require registration but face lower scrutiny. Class D devices are subject to the most rigorous regulatory review, including mandatory clinical investigation data and CDSCO technical committee evaluation. Manufacturers must confirm their device classification before initiating the registration process, as misclassification can cause significant delays.
What Is the Step-by-Step CDSCO Registration Process for Medical Devices in India?
CDSCO medical device registration in India follows a structured, multi-stage process. Altacit Global recommends initiating registration planning at least 12 to 18 months before the intended market entry date for Class C and Class D devices.
Step 1: Prepare Technical Documentation
Applicants must compile a comprehensive technical file, which includes:
- Device description and intended use
- Risk analysis and risk management report (aligned with ISO 14971)
- Design and manufacturing information
- Labelling in compliance with Schedule V of the Medical Devices Rules 2017
- Performance and safety test reports from NABL-accredited or internationally recognized laboratories
- Quality Management System (QMS) certificate (IS 13485 / ISO 13485)
- Clinical data or performance evaluation reports (mandatory for Class C and Class D devices)
For imported devices, the overseas manufacturer must appoint an Indian Authorized Agent (IAA) who assumes regulatory responsibility in India.
Step 2: Application on SUGAM Portal
All applications for medical device licence in India are submitted electronically through the SUGAM portal (sugam.pharma.gov.in). The SUGAM portal is the central digital interface between applicants and CDSCO for all registration, import licence, and manufacturing licence applications.
Applicants must create an account, select the appropriate form (Form MD-3 for registration or Form MD-5 for import licence), upload all technical documents, and pay the prescribed government fee online.
Step 3: Technical Scrutiny by CDSCO
Upon submission, CDSCO assigns the application to a reviewing officer. For Class A and Class B devices, scrutiny is typically administrative in nature. For Class C and Class D devices, CDSCO may refer the application to the Medical Device Technical Advisory Group (MDTAG) or require additional clinical data.
CDSCO may raise queries requesting supplementary documentation. Applicants must respond within the stipulated timeframe to avoid application lapse.
Step 4: Grant of Registration Certificate
Upon successful review, CDSCO issues a Registration Certificate (Form MD-15) for imported devices or a Manufacturing Licence (Form MD-9) for domestically manufactured devices. Registration certificates are typically valid for a defined period, with renewal obligations before expiry.
Timelines vary by device class. Class A devices can receive approval in approximately three to six months. Class D devices may require 12 to 24 months, depending on the completeness of clinical data and MDTAG review cycles.
What Is the BIS Mandatory Certification Requirement for Medical Devices in India?
The Bureau of Indian Standards (BIS) has introduced mandatory certification for select medical device categories under the BIS Act 2016. The applicable Indian Standard is IS 13485, which is harmonized with ISO 13485 (Medical Devices Quality Management Systems).
BIS certification requires manufacturers to demonstrate compliance with IS 13485 through a conformity assessment conducted by a BIS-recognized body. For imported devices, BIS applies the Foreign Manufacturers Certification Scheme (FMCS), which requires overseas manufacturers to obtain BIS certification before their products can be imported into India.
Manufacturers should note that BIS certification and CDSCO registration are separate regulatory requirements. Both must be obtained to lawfully market and sell notified medical devices in India. Failure to hold valid BIS certification where mandated constitutes a violation of the Legal Metrology and BIS Act provisions.
Altacit Global assists clients in coordinating both BIS certification and CDSCO registration simultaneously to minimize regulatory lead times.
What Are the Clinical Investigation Requirements for Class C and Class D Devices?
Clinical investigations for high-risk medical devices in India are governed by the Medical Devices Rules 2017 and the New Drugs and Clinical Trials Rules 2019. Class C and Class D devices must be supported by clinical data demonstrating safety and performance for the Indian population.
Clinical investigations must be conducted at CDSCO-approved clinical sites and overseen by qualified principal investigators. Ethics Committee (EC) approval from a registered Ethics Committee is mandatory before any clinical investigation commences.
Key regulatory requirements include:
- Submission of clinical investigation application to CDSCO along with the investigational device dossier
- CDSCO approval before subject enrollment begins
- Compliance with Good Clinical Practice (GCP) guidelines issued by CDSCO
- Submission of periodic safety reports and a final clinical investigation report to CDSCO
Devices with existing clinical data from studies conducted in recognized jurisdictions (such as the United States, European Union, or Japan) may submit that data to CDSCO. However, CDSCO retains the authority to require bridging studies for the Indian population.
How Can Medical Device Companies Protect IP in India?
Intellectual property protection is a critical element of market entry strategy for medical device companies. Altacit Global advises clients to pursue IP protection in parallel with CDSCO registration to prevent unauthorized replication.
The primary IP instruments applicable to medical devices in India are:
Patents: Device technology, novel manufacturing processes, and software algorithms embedded in medical devices are patentable under the Patents Act 1970. Altacit Global assists clients in preparing and prosecuting patent applications before the Indian Patent Office. (See our guide on Patent Filing in India)
Design Registration: The visual features and aesthetic configuration of medical devices can be protected under the Designs Act 2000. India acceded to the Riyadh Design Law Treaty in 2025, which modernizes the international framework for industrial design protection. (See our article on Design Registration in India)
Trade Secrets: Proprietary manufacturing formulations, calibration processes, and clinical protocols that are not disclosed in patent filings can be protected as trade secrets under contract law and confidentiality frameworks. (See our overview of Trade Secrets Protection)
Trademarks: Device brand names and logos should be registered under the Trade Marks Act 1999 to protect market identity and prevent passing off. (See our overview of Trade Marks Protection)
Companies entering India’s medical device market should conduct freedom-to-operate (FTO) analysis and file relevant IP applications before public disclosure of the device or regulatory submission.
What Are the FDI Rules for Medical Device Manufacturing in India?
India permits 100% Foreign Direct Investment (FDI) under the automatic route for medical device manufacturing. This means foreign investors do not require prior government approval to establish or acquire a medical device manufacturing entity in India.
The Government of India has further incentivized domestic manufacturing through the Production Linked Incentive (PLI) Scheme for Medical Devices, which carries a budgetary outlay of INR 3,420 crore. The PLI Scheme provides financial incentives to eligible manufacturers based on incremental sales over a base year, making India an increasingly competitive manufacturing destination.
Foreign companies entering India through the FDI route must ensure compliance with the Foreign Exchange Management Act 1999 (FEMA), the Companies Act 2013, and sector-specific CDSCO requirements for foreign manufacturer registration. Structuring the Indian entity correctly from the outset minimizes downstream compliance risk. (See our guidance on FDI Structuring for Corporate Entities)
Altacit Global provides end-to-end advisory for FDI structuring in the medical device sector, including entity setup, PLI Scheme applications, and CDSCO registration coordination for multinational manufacturers.
Start Your CDSCO Compliance Process with Altacit Global
Navigating medical device regulation in India requires precise documentation, regulatory strategy, and coordination across multiple authorities, including CDSCO, BIS, the Indian Patent Office, and the Department for Promotion of Industry and Internal Trade (DPIIT).
Altacit Global provides comprehensive legal and regulatory advisory services for medical device companies, including:
- CDSCO registration and medical device licence applications
- BIS IS 13485 certification coordination
- Clinical investigation compliance under the New Drugs and Clinical Trials Rules 2019
- Patent filing, design registration, and trade secret structuring
- FDI structuring and PLI Scheme applications for medical device manufacturers
To initiate your CDSCO registration or to discuss your market entry strategy for India, contact our team at info@altacit.com.
Frequently Asked Questions: Medical Device Regulation India
Q1: What is the difference between a Class A and Class D medical device in India?
Class A devices present low risk to patients and users, such as bandages or examination gloves, and follow a simplified CDSCO registration process with minimal technical documentation requirements. Class D devices present high risk, such as heart valves or active implantable devices, and require comprehensive technical documentation, clinical investigation data, and review by the Medical Device Technical Advisory Group (MDTAG) before CDSCO approval is granted.
Q2: How long does CDSCO registration take for a medical device in India?
CDSCO registration timelines depend on device classification. Class A devices may receive registration certificates in approximately three to six months from a complete application submission. Class B devices typically take six to nine months. Class C and Class D devices, which require MDTAG review and clinical data evaluation, may take 12 to 24 months. Incomplete applications or delayed responses to CDSCO queries significantly extend these timelines.
Q3: Is ISO 13485 mandatory for medical device companies operating in India?
ISO 13485 (implemented in India as IS 13485 by the Bureau of Indian Standards) is effectively mandatory for manufacturers of notified medical devices seeking CDSCO registration. CDSCO requires manufacturers to demonstrate a functioning Quality Management System aligned with IS 13485 as part of the technical documentation. For devices subject to BIS mandatory certification, IS 13485 compliance is a direct certification prerequisite.
Q4: Can a medical device be sold in India before CDSCO registration is obtained?
No. Medical devices falling within notified categories under the Medical Devices Rules 2017, and all other devices as of April 1, 2021, cannot be lawfully manufactured for sale, imported, or distributed in India without valid CDSCO registration or a manufacturing licence. Selling an unregistered medical device in India constitutes a violation under the Drugs and Cosmetics Act 1940 and may result in product seizure, prosecution, and import restrictions.
